NCT04922892 Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism
| NCT ID | NCT04922892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Second Hospital of Nanjing Medical University |
| Condition | Secondary Hyperparathyroidism;Parathyroidectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-06-01 |
| Primary Completion | 2023-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2021-06-01 with a primary completion date of 2023-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total parathyroidectomy with autotransplantation (TPTX+AT) and Total parathyr- oidectomy alone (TPTX) are the common surgical procedures.The purpose of the study was to compare the long-term benefits of surgery between the two groups.
Eligibility Criteria
Inclusion Criteria: Severe renal secondary hyperparathyroidism Exclusion Criteria: Patients with diabetes a history of chronic inflammatory disease a history of malignant tumor a history of kidney transplantation a history of neck surgery a history of alcohol abuse a history of drug abuse inability to cooperate with the participants refusal to participate in the study
Contact & Investigator
Mingxia XIONG, Ph.D
STUDY DIRECTOR
Nanjing Medcial university
Frequently Asked Questions
Who can join the NCT04922892 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Secondary Hyperparathyroidism;Parathyroidectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04922892 currently recruiting?
Yes, NCT04922892 is actively recruiting participants. Contact the research team at xiongmingxia@njmu.edu.cn for enrollment information.
Where is the NCT04922892 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT04922892 clinical trial?
NCT04922892 is sponsored by The Second Hospital of Nanjing Medical University. The principal investigator is Mingxia XIONG, Ph.D at Nanjing Medcial university. The trial plans to enroll 200 participants.